Clinical trial
Coronary Flow Reserve Following Orbital Atherectomy and Percutaneous Revascularization in Severely Calcified Coronary Lesions
NCT02339545 is registered in ClinicalTrials.gov with Abbott Medical Devices as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Coronary Flow Reserve Following Orbital Atherectomy and Percutaneous Revascularization in Severely Calcified Coronary Lesions
- Lead sponsor
- Abbott Medical Devices
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 28, 2015
- Completion date
- May 31, 2016
- Enrollment
- 15 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.